» Articles » PMID: 17119392

Psychotherapy with Chronic Inflammatory Bowel Disease Patients: a Review

Overview
Specialty Gastroenterology
Date 2006 Nov 23
PMID 17119392
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Two distinct factors have lead in the past to the development of several psychotherapeutic treatments for patients with inflammatory bowel diseases (IBD). First, clinicians and researchers believe that psychologic and somatic factors in chronic IBD, Crohn's disease, and ulcerative colitis) are connected. In addition, IBD reduces the health-related quality of life for these patients. The purpose of the psychotherapies is to influence the somatic course of the disease, the psychological state of the patients, or the patients' health related quality of life. This report evaluates the existing studies with regard to the effectiveness of psychotherapy IBD patients received in addition to medical treatment. We have identified 10 psychotherapy studies and 4 additional studies on self management and patient education on this topic. The studies significantly differ from each other in regard to psychotherapeutic methods, inclusion criteria, and outcome assessments. The results so far lead to the conclusion that psychotherapy does not have an impact on the course of the disease but, in some cases, positively influences the patient's psychologic state (such as depression, anxiety, and health related quality of life or coping with the disease). Thus, psychotherapy cannot, in general, be recommended for all patients with chronic IBD. Patients, however, that display a tendency toward psychologic problems, especially as it pertains to their illness, might profit from it.

Citing Articles

Attitudes and knowledge for CBT-based psychotherapy among medical students and residents in China: a survey study.

Ding Y, Pei T, Peng P, Yao J, Tang J, Liao Y BMC Med Educ. 2025; 25(1):68.

PMID: 39815284 PMC: 11734226. DOI: 10.1186/s12909-025-06641-w.


Investigating resilience in patients with IBD: preliminary insights for understanding disease-specific resilience skills.

Mendiolaza M, Ogundipe T, Arroyave-Villada J, Adeonigbagbe O, Gorbenko K, Keefer L Front Psychol. 2024; 15:1486401.

PMID: 39606191 PMC: 11599970. DOI: 10.3389/fpsyg.2024.1486401.


Comparing the effectiveness of online individualized transdiagnostic treatment with acceptance and commitment therapy on medication adherence, gastrointestinal symptoms and perceived stress of patients with irritable bowel syndrome.

Shahkaram H, Sadeghi A, Masjedi Arani A, Bakhtiari M, Kianimoghadam A Gastroenterol Hepatol Bed Bench. 2024; 17(3):288-296.

PMID: 39308538 PMC: 11413384. DOI: 10.22037/ghfbb.v17i3.2920.


Brief and Telehealth Acceptance and Commitment Therapy (ACT) Interventions for Stress in Inflammatory Bowel Disease (IBD): A Series of Single Case Experimental Design (SCED) Studies.

Lavelle J, Storan D, Eswara Murthy V, De Dominicis N, Mulcahy H, McHugh L J Clin Med. 2022; 11(10).

PMID: 35628884 PMC: 9145285. DOI: 10.3390/jcm11102757.


The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review.

Chen J, Chen X, Sun Y, Xie Y, Wang X, Li R BMC Gastroenterol. 2021; 21(1):469.

PMID: 34911469 PMC: 8672154. DOI: 10.1186/s12876-021-02003-0.